Sunday, October 1, 2017

ARNA Genomics

ARNA Genomics are an innovative biotechnological company, launched by a team of like-minded scientists and businessmen and grown from the scientific and research laboratory into full scale venture. ARNA develop revolutionary early detection methods for select cancers in order to launch a line of diagnostic tests for early cancer detection on the global markets

Our mission: to increase the life expectancy and significantly reduce human mortality. ARNA relentlessly pursue this goal through cutting edge screening methods, diagnosis correction, treatment monitoring, and increasing patient adherence.

Our Innovation: ARNA Genomics has discovered a technology enabling highly specific tests development for different cancers. Besides, the company has also developed a unique concept of blockchain-based ecosystem-grade platform intended for use as an instrument to support R&D and implementation of biotechnologies worldwide.

Our Pledge: ARNA Genomics have completed R&D for its first product - ARNA Breast Cancer test. The test for colon cancer test is currently in an advanced R&D stage. ARNA devote all our resources to complete development of ARNA Panacea - a blockchain platform, that will hope will change the world by making launch of new biotech and treatment solutions against cancers much easier, cheaper and faster.

ARNA Panacea development

ARNA Genomics will provide to all market players working with cancer a fundamentally new way to access and interact with the clinical trials data collection and storage environment. Using ARNA tokens the holders would be able to pay for other system members services (e.g. cancer check-ups, tests, etc.), get access to the medical trial data storage system for professional medical use, pay for other system users services or start fundraising to perform a new study.

In cooperation with FDA regulator (U.S. Food and Drug Administration), ARNA Genomics will test the corresponding Data Storage System to collect evidential base to be used by the regulator for further product licensing opportunities (Breast cancer detection ARNA BC) for the US mass market. ARNA Genomics will be using the existing methodology and “best practices” available for the successful development and implementation of this solution for all members of the ARNA Panacea ecosystem:

  • Discuss and Discover: the first phase of the project would include discussion and evaluation of the key market players requirements in terms of their adaptability towards the Blockchain technology, as well as all of the technical requirements.
  • Design & Prototype: this phase deals with the Blockchain node prototype development in affiliation with our trusted partners in order to evaluate and perform comprehensive functionality testing of the ARNA Panacea ecosystem.
  • Development: the basic system model development will be completed during this phase.
  • Deployment: this phase involves the deployment of the ARNA Panacea ecosystem as well as the involvement of new partners and market players.
  • Application Support: ARNA Genomics will continue to support the system and its members for an indefinite period of time.  

More Info
Website :
Whitepaper :
Facebook :
Twitter :
Telegram :
Medium :
Linkedin :

Author : mriansa;u=886049
Share This
Previous Post
Next Post